Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Ulrich Jäger, MD, Medical University of Vienna, Vienna, Austria, discusses patient selection for CAR-T therapy, drawing focus on factors that need to be considered when selecting patients and the process of patient selection in the Austrian CAR-T cell network. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.